Drug Database
Back to search

Poland· PL-100268076

Dificlir

A fidaxomicin product containing fidaxomicinum, registered in Poland by Tillotts Pharma GmbH. The same ATC class is registered in 16 of our 19 countries.

ATC A07AA12

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDificlirATCA07AA12REGISTER NO.PL-100268076PACKS LISTED5CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fidaxomicinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fidaxomicin is registered in 16 of 19 countries.

Countries holding a registration under ATC A07AA12 (fidaxomicin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search fidaxomicin products by name

Fidaxomicin · ATC A07AA12

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fidaxomicin costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Fidaxomicin · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$179.87
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Fidaxomicinum
Manufacturer
Tillotts Pharma GmbH
Country
Poland (PL)
ATC code
A07AA12
ATC class
Fidaxomicin
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909990935703
  • gtin
    05909990935673
  • gtin
    07640129622146
  • gtin
    05909990935680
  • gtin
    05909990935697

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

101 interactions on record for fidaxomicin.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check fidaxomicin against other medicinesHow interaction checks work

Fidaxomicin · interactions on record

101 records

  • 3 severe
  • 24 moderate
  • 74 minor

Most severe, free to view

  • BerotralstatB06AC06severe
  • VenetoclaxL01XX52severe
  • RelugolixL02BX04severe
  • Sodium picosulfateA06AB08moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fidaxomicin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fidaxomicin products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • France · Fidaxomicine Sun
  • United Kingdom (Northern Ireland) · Fidaxomicin Tillotts 200 Mg, Fidaxomicin Tillotts 40 Mg/Ml
  • Iceland · Dificlir
  • Liechtenstein · Dificlir, Dificlir 200 Mg
  • Norway · Dificlir, Dificlir 200 Mg
  • Sweden · Fidaxomicin Sun

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/950eef95-a09b-405b-ac93-449420b74258
GET /v1/drugs/950eef95-a09b-405b-ac93-449420b74258?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "200 mg",
  "packaging": "05909990935680 ¦ Rp ¦ Skasowane ¦ EU/1/11/733/002 ¦ 44462\n60 tabl. w butelce\n05909990935697 ¦ Rp ¦ EU/1/11/733/003 ¦ 44672\n100 tabl.\n05909990935703 ¦ Rp ¦ Skasowane ¦ EU/1/11/733/004 ¦ 44703\n20 tabl. w blistrze\n05909990935673 ¦ Rp ¦ Skasowane ¦ EU/1/11/733/001 ¦ 72587\n20 tabl. w butelce\n07640129622146 ¦ Rp ¦ EU/1/11/733/004 ¦ 140117\n20 tabl.",
  "substance": "Fidaxomicin 200 mg",
  "common_name": "Fidaxomicinum",
  "pl_product_id": "100268076",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about fidaxomicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console